DE69004529T2 - Verwendung von Sertralin zur Behandlung von Abhängigkeiten von chemischen Stoffen. - Google Patents

Verwendung von Sertralin zur Behandlung von Abhängigkeiten von chemischen Stoffen.

Info

Publication number
DE69004529T2
DE69004529T2 DE90309062T DE69004529T DE69004529T2 DE 69004529 T2 DE69004529 T2 DE 69004529T2 DE 90309062 T DE90309062 T DE 90309062T DE 69004529 T DE69004529 T DE 69004529T DE 69004529 T2 DE69004529 T2 DE 69004529T2
Authority
DE
Germany
Prior art keywords
sertraline
treat chemical
chemical addiction
mammal
dependency
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE90309062T
Other languages
English (en)
Other versions
DE69004529D1 (de
Inventor
Peter A Bick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23584453&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69004529(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of DE69004529D1 publication Critical patent/DE69004529D1/de
Publication of DE69004529T2 publication Critical patent/DE69004529T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Addiction (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
  • General Factory Administration (AREA)
  • Saccharide Compounds (AREA)
DE90309062T 1989-08-30 1990-08-17 Verwendung von Sertralin zur Behandlung von Abhängigkeiten von chemischen Stoffen. Expired - Fee Related DE69004529T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40064789A 1989-08-30 1989-08-30

Publications (2)

Publication Number Publication Date
DE69004529D1 DE69004529D1 (de) 1993-12-16
DE69004529T2 true DE69004529T2 (de) 1994-02-24

Family

ID=23584453

Family Applications (1)

Application Number Title Priority Date Filing Date
DE90309062T Expired - Fee Related DE69004529T2 (de) 1989-08-30 1990-08-17 Verwendung von Sertralin zur Behandlung von Abhängigkeiten von chemischen Stoffen.

Country Status (16)

Country Link
EP (1) EP0415612B1 (de)
JP (1) JPH0393719A (de)
KR (1) KR930000049B1 (de)
AT (1) ATE96999T1 (de)
AU (1) AU617622B2 (de)
CA (1) CA2024181C (de)
DE (1) DE69004529T2 (de)
DK (1) DK0415612T3 (de)
HU (1) HUT58513A (de)
IE (1) IE63137B1 (de)
IL (1) IL95472A (de)
MY (1) MY106939A (de)
NZ (1) NZ235100A (de)
PH (1) PH27544A (de)
PT (1) PT95118B (de)
ZA (1) ZA906882B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0415612B1 (de) * 1989-08-30 1993-11-10 Pfizer Inc. Verwendung von Sertralin zur Behandlung von Abhängigkeiten von chemischen Stoffen
IL152330A0 (en) 1997-07-01 2003-05-29 Pfizer Sertraline salts and sustained-release dosage forms of sertraline
EA002481B1 (ru) * 1997-07-01 2002-06-27 Пфайзер Продактс Инк. Композиция на основе солюбилизированного сертралина
BR9914418A (pt) * 1998-10-13 2001-06-26 Pfizer Prod Inc Concentrado oral de sertralina
US6727283B2 (en) 1998-10-13 2004-04-27 Pfizer Inc. Sertraline oral concentrate
GB2392385A (en) * 2002-09-02 2004-03-03 Cipla Ltd Pharmaceutical preparations comprising a 5HT uptake inhibitor and a homopolymer or copolymer of N-vinyl pyrrolidone

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
US4999382A (en) * 1988-10-26 1991-03-12 Massachusetts Institute Of Technology Compositions for treating tobacco withdrawal symptoms and methods for their use
EP0415612B1 (de) * 1989-08-30 1993-11-10 Pfizer Inc. Verwendung von Sertralin zur Behandlung von Abhängigkeiten von chemischen Stoffen
US4962128A (en) * 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline

Also Published As

Publication number Publication date
KR910004188A (ko) 1991-03-28
IE903124A1 (en) 1991-03-13
ZA906882B (en) 1992-04-29
ATE96999T1 (de) 1993-11-15
EP0415612A2 (de) 1991-03-06
MY106939A (en) 1995-08-30
JPH0393719A (ja) 1991-04-18
PT95118A (pt) 1991-05-22
AU6194390A (en) 1991-04-18
PT95118B (pt) 1997-05-28
IL95472A (en) 1996-05-14
DE69004529D1 (de) 1993-12-16
KR930000049B1 (ko) 1993-01-06
CA2024181A1 (en) 1991-03-01
HUT58513A (en) 1992-03-30
PH27544A (en) 1993-08-18
AU617622B2 (en) 1991-11-28
EP0415612B1 (de) 1993-11-10
CA2024181C (en) 1994-11-08
EP0415612A3 (en) 1992-02-19
HU905683D0 (en) 1991-03-28
IE63137B1 (en) 1995-03-22
DK0415612T3 (da) 1993-12-13
NZ235100A (en) 1997-05-26

Similar Documents

Publication Publication Date Title
DE69012261T2 (de) Verwendung von Sertralin zur Behandlung verfrühter Ejakulation.
DE69033903D1 (de) Verwendung von Sertraline zur Herstellung eines Arzneimittels zur Behandlung von obsessiv-kompulsiven Erkrankungen
DE3779149D1 (de) Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit.
ATE96999T1 (de) Verwendung von sertralin zur behandlung von abhaengigkeiten von chemischen stoffen.
DE69304843T2 (de) Methode zur Behandlung von Haarausfall
ATE235237T1 (de) Sertralin zur behandlung von post-myocard-infarkt-patienten
ATE299021T1 (de) Verwendung von oxazolidinonderivaten zur behandlung von psoriasis

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee